Abstract:Background: Expression of cyclooxygenase (COX)-2 can be detected in the hepatocellular carcinoma (HCC). Aspirin, a non-steroidal anti-inflammatory drug, can inhibit the growth of HCC probably through the inhibition of COX-2 expression. Aims: To compare the effects of three kinds of selective COX-2 inhibitors (meloxicam, celecoxib and rofecoxib) on the growth of human liver cancer cell line SMMC-7721, and to observe the effect of rofecoxib, a highly selective COX-2 inhibitor, on the growth of HCC implanted in the liver of nude mice. Methods: The DNA synthesis of SMMC-7721 cells was determined by 3H-thymidine (3H-TdR) incorporation method. The expression of proliferating cell nuclear antigen (PCNA) was detected by immunocytochemistry. The terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) assay was used to detect cell apoptosis. Rofecoxib (30 mg/kg per day) was administered to HCC implanted nude mice for eight weeks, the volume and weight of the xenografts in situ were measured. Results: Meloxicam, celecoxib and rofecoxib could decrease the 3H-TdR incorporation significantly in a dose-dependent manner in SMMC-7721 cells. Their 50% inhibitory concentration (IC50) were 8.55×10-8 mol/L, 1.22×10-8 mol/L and 6.27×10-9 mol/L, respectively. After treated with the above three selective COX-2 inhibitors (1×10-5 mol/L) for 24 hours, the expression of PCNA in SMMC-7721 cells were decreased, and the apoptosis index was significantly increased compared with that of the controls (14.6%±2.8%, 21.6%±3.6% and 27.1%±3.5% vs. 1.0%±0.7%, P<0.01). The higher the selectivity of COX-2, the higher the apoptosis index (P<0.01). The xenografts in situ in nude mice treated with rofecoxib were significantly smaller than those of the controls, and the inhibition rates were 73.2% in volume and 78.1% in weight. Conclusions: All three kinds of selective COX-2 inhibitors can effectively inhibit the growth of SMMC-7721 cells in vitro in proportion to their selectivity. The inhibition of HCC growth in vivo by rofecoxib suggests it may be an effective drug in the treatment of HCC.

The Effects of Selective Cyclooxygenase-2 Inhibitors on the Growth of Human Pancreatic Cellular Carcinoma

[Effect of Selective Cyclooxygenase-2 Inhibitor Celebrex on Expression of Vascular Endothelial Growth Factor (VEGF) in Pancreatic Carcinoma].

Impact of the Selective Cyclooxygenase-2 Inhibitor Celebrex on Angiogenesis in Pancreatic Carcinoma

[The Effects of Selective Cyclooxygenase-2 Inhibitors on the Growth of Gastric Adenocarcinoma].

Effects of Three Kinds of Selective Cyclooxygenase-2 Inhibitors on the Growth of Hepatocellular Carcinoma

Cyclooxygenase-2 Induces Angiogenesis in Pancreatic Cancer Mediated by Prostaglandin E-2

Expression of COX-2 in Primary Ovarian Carcinoma and the Effects of Celecoxib on the Cell Proliferation of the Human Ovarian Carcinoma Cell Line A2780

Selective Inhibition of Cyclooxygenase-2 Suppresses the Growth of Pancreatic Cancer Cells in Vitro and in Vivo

Therapeutic Effects of COX-2 Inhibitor Celecoxib on Nude Mice Bearing Human Pancreatic Cancer Xenograft

[Effects of Rofecoxib on Angiogenesis of Pancreatic Cancer Xenograft in Nude Mice].

Radiosensitizing Effect of Celecoxib on Human Pancreatic Carcinoma

The Effects of Inhibited the Proliferation by Celecoxib in Human Primary Hepatic Cancer Xenograft of Nude Mice in Vivo

Influence of Selective Cyclooxygenase- 2 Inhibitor Rofecoxib on Proliferation of Human Gastric Adenocarcinoma Cells

Combined Effects of Cyclooxygenase-1 and Cyclooxygenase-2 Selective Inhibitors on Ovarian Carcinoma in Vivo.

Inhibitory Effects of Cyclooxygenase-2 Inhibitory Drugs on Human Osteosarcoma and Lung Cancer Cell Lines

The Inhibitory Effect of Rofecoxib on Pancreatic Cancer Via ERK and AP-1

Study on Inhibition Effects of Meloxicam on Growth of Hepatocellular Carcinoma

The Effect of a Selective COX-2 Inhibitor on Cell Growth in Human Colorectal Cancer Cell Line

Experimental Study on Inhibitive Effect of a Non-Steroidal Anti-Inflammatory Drug,celecoxib,on Lung Adenocarcinoma

[Effects of Selective and Non-Selective Cyclooxygenase-2 Inhibitor on the Growth of Colon Cancer Cells].

Celecoxib Inhibits Proliferation and Induces Apoptosis Via Cyclooxygenase-2 Pathway in Human Pancreatic Carcinoma Cells